Application of LION/repRNA to develop vaccines and therapies for infectious diseases and cancer
This hybrid seminar will provide an introduction to HDT鈥檚 technology with the goal of identifying collaborations with Canadian investigators in oncology and infectious disease spaces. D2R is hosting HDT Bio for a hybrid seminar to highlight their cutting-edge work at the intersection of RNA therapeutics and immunology, and to foster dialogue around innovative platform technologies with potential for broad applications in infectious diseases, oncology, and beyond.
